Samsung Biologics ranked among the top searched stocks for 10 days in the past month.

As of 2:33 PM on the 15th, Samsung Biologics is trading at 806,000 KRW, up 0.12% from the previous day. This marks a 35.01% increase compared to May 18. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have sold a net 27,248 shares of Samsung Biologics, and institutions have sold a net 2,000 shares, according to provisional data. Over the past five days, individual investors have sold a net 106,009 shares, while foreigners and institutions have bought a net 73,665 shares and 19,963 shares, respectively.

On June 12, Samsung Biologics made headlines in the market for "consecutively reaching all-time highs... breaking through 800,000 KRW."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing